XML 73 R56.htm IDEA: XBRL DOCUMENT v3.24.4
FAIR VALUE MEASUREMENT - Schedule of Contingent Consideration Measured at Fair Value (Details) - Contingent Consideration - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 7,976 $ 5,920
Expenses recorded due to changes in fair value 136 2,056
Cash payment of contingent consideration associated with the ID R&D Acquisition (4,641)  
Issuance of common stock as contingent consideration associated with the ID R&D Acquisition (3,471)  
Ending balance $ 0 $ 7,976